Sutro Biopharma (STRO) Prepaid Assets (2017 - 2026)

Sutro Biopharma has reported Prepaid Assets for 9 years, with the latest figure at $5.5 million in Q4 2025.

• Quarterly Prepaid Assets fell 68.98% year-over-year to $5.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.5 million (down 68.98% YoY) and the FY2025 annual result came in at $5.5 million, down 68.98% from the prior year.
• Prepaid Assets fell to $5.5 million in Q4 2025 per STRO's latest filing, from $10.6 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $24.9 million in Q1 2025 and troughed at $5.5 million in Q4 2025.
• A 5-year average of $11.5 million and a median of $10.2 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2021 and 2025: Prepaid Assets soared 232.69% in 2021, then tumbled 68.98% in 2025.
• Over 5 years, Prepaid Assets stood at $8.1 million in 2021, then soared by 43.63% to $11.7 million in 2022, then slipped by 15.61% to $9.8 million in 2023, then surged by 80.77% to $17.8 million in 2024, then tumbled by 68.98% to $5.5 million in 2025.
• According to Business Quant data, Prepaid Assets over the past three periods registered $5.5 million, $10.6 million, and $18.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.